The evolving landscape of neuromodulation for pain care.

IF 11.7 1区医学 Q1 CELL BIOLOGY

Cell Reports Medicine Pub Date : 2024-10-15 DOI:10.1016/j.xcrm.2024.101787

Jean-Pascal Lefaucheur, Yinghui Fan, Bifa Fan, Perianen Ramasawmy, Andrea Antal, Dimos D Mitsikostas, Cecile De Vos

引用次数: 0

Abstract

Here, we present five different insights on the use of neuromodulation strategies for effective pain management in clinical practice. Experts briefly illustrate the various techniques available and the complexities involved in evaluating their effectiveness. Additionally, they highlight the challenges for widespread adoption in clinical practice and explore some future directions. These viewpoints underscore the evolving landscape of neuromodulation in pain management and the ongoing efforts to optimize these treatments for diverse patient needs.

查看原文本刊更多论文

用于疼痛治疗的神经调控技术不断发展。

在此，我们将介绍在临床实践中使用神经调控策略有效控制疼痛的五种不同见解。专家们简要说明了现有的各种技术以及评估其有效性所涉及的复杂性。此外，他们还强调了在临床实践中广泛采用这些技术所面临的挑战，并探讨了一些未来的发展方向。这些观点强调了神经调控在疼痛治疗中不断发展的前景，以及为满足不同患者需求而不断优化这些治疗方法的努力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cell Reports Medicine Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)

CiteScore

15.00

自引率

1.40%

发文量

231

审稿时长

40 days

期刊介绍： Cell Reports Medicine is an esteemed open-access journal by Cell Press that publishes groundbreaking research in translational and clinical biomedical sciences, influencing human health and medicine. Our journal ensures wide visibility and accessibility, reaching scientists and clinicians across various medical disciplines. We publish original research that spans from intriguing human biology concepts to all aspects of clinical work. We encourage submissions that introduce innovative ideas, forging new paths in clinical research and practice. We also welcome studies that provide vital information, enhancing our understanding of current standards of care in diagnosis, treatment, and prognosis. This encompasses translational studies, clinical trials (including long-term follow-ups), genomics, biomarker discovery, and technological advancements that contribute to diagnostics, treatment, and healthcare. Additionally, studies based on vertebrate model organisms are within the scope of the journal, as long as they directly relate to human health and disease.